Xiao-Fei An Selected Research

(5- (2- methylphenoxymethy)- 1,3- oxazolin- 2- yl) amine

7/2012

Characterization of the hypothermic effects of imidazoline I₂ receptor agonists in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Fei An Research Topics

Disease

4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 02/2010
3	Graves Disease (Basedow Disease) 01/2019 - 01/2018
2	Fibrosis (Cirrhosis) 10/2022 - 11/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 03/2010
2	Thyroid Diseases (Thyroid Disease) 01/2018 - 08/2016
2	Thyroiditis 01/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 03/2010
1	Ureteral Obstruction 10/2022
1	Chronic Renal Insufficiency 01/2022
1	Body Weight (Weight, Body) 11/2020
1	Atrophic Gastritis 08/2020
1	Atrophy 08/2020
1	Carcinogenesis 08/2020
1	Inflammation (Inflammations) 07/2017
1	Asthma (Bronchial Asthma) 07/2017
1	Nervous System Diseases (Neurological Disorders) 01/2014
1	Cognitive Dysfunction 01/2014
1	Hypothermia 07/2012
1	Pain (Aches) 05/2012
1	Diabetes Complications 08/2011
1	Atherosclerosis 03/2010
1	AIDS-Related Complex (ARC) 11/2003

Drug/Important Bio-Agent (IBA)

3	Advanced Glycation End ProductsIBA 08/2011 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 08/2016
2	ImidazolinesIBA 07/2012 - 05/2012
1	MethyltransferasesIBA 10/2022
1	artemisinin (artemisinine)IBA 10/2022
1	artenimol (dihydroartemisinin)IBA 10/2022
1	Adenine FDA LinkGeneric 10/2022
1	Azacitidine (5 Azacytidine)FDA Link 10/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	PAR-1 ReceptorIBA 01/2022
1	Thrombin Receptors (Thrombin Receptor)IBA 01/2022
1	Saline SolutionIBA 11/2020
1	Methyl MethanesulfonateIBA 11/2020
1	Untranslated RNA (Noncoding RNA)IBA 08/2020
1	Circular RNAIBA 08/2020
1	Cytochrome P-450 CYP2C19IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Histones (Histone)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2018
1	SteroidsIBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	Ligases (Synthetase)IBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 07/2017
1	Antiviral Agents (Antivirals)IBA 07/2017
1	Volatile Oils (Essential Oils)IBA 07/2017
1	Prorenin ReceptorIBA 01/2017
1	Type 1 Angiotensin ReceptorIBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	CR4056IBA 07/2012
1	Yohimbine (Yocon)IBA 07/2012
1	IdazoxanIBA 07/2012
1	(5- (2- methylphenoxymethy)- 1,3- oxazolin- 2- yl) amineIBA 07/2012
1	tracizolineIBA 07/2012
1	BU 224IBA 07/2012
1	efaroxanIBA 07/2012
1	phenyzolineIBA 07/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2012
1	Opioid Analgesics (Opioids)IBA 05/2012
1	Streptozocin (Streptozotocin)FDA Link 05/2012
1	GlycosidesIBA 05/2012
1	hyperosideIBA 05/2012
1	flavoneIBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 03/2010
1	C-Reactive ProteinIBA 03/2010
1	Protein Isoforms (Isoforms)IBA 02/2010
1	Receptor for Advanced Glycation End ProductsIBA 02/2010
1	Carbachol (Carbastat)FDA Link 11/2003

Therapy/Procedure

2	Oral Administration 10/2022 - 01/2020
2	Therapeutics 01/2014 - 05/2012
1	Moxibustion 08/2020